Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 111,086 shares at $20.67 ($2.4M) on 2019-02-28, disclosed to the SEC on 2019-03-01.
Open-market sale of $2.4M AMRN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.67 | 9,543 | $197K | 8.1% |
| 2 | $20.67 | 9,543 | $197K | 8.1% |
| 3 | $20.94 | 3,503 | $73K | 3.0% |
| 4 | $20.94 | 3,503 | $73K | 3.0% |
| 5 | $22.10 | 35,398 | $782K | 32.2% |
| 6 | $22.10 | 35,398 |
| $782K |
| 32.2% |
| 7 | $22.64 | 7,099 | $161K | 6.6% |
| 8 | $22.64 | 7,099 | $161K | 6.6% |
| Total | $21.85 avg | 111,086 | $2.4M | 100% |
| Filing → |
| AMRN | SELL | 2021-01-29 | $6.8M | — | Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |